Sandu Pharmaceuticals Complete Financial Statements

5 Years of Data

2025 - 2021

In FY2025, Sandu Pharmaceuticals (SANDUPHQ) reported revenue ₹14 Cr, net profit ₹0 Cr and EPS ₹0.34. Full financial statements from FY2021 to FY2025 (5 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review SANDUPHQ price earnings ratio to evaluate earnings-based valuation against sector peers.

Complete Financial Data Export

Profitability Ratios

EBITDA Margin 7.14% 2025 data

Operating Margin 3.00% 2025 data

Balance Sheet Ratios

Current Ratio 13.00 2025 data

Equity Ratio 75.00% 2025 data

Asset Turnover 0.25 2025 data

SANDUPHQ Revenue, Net Profit & EBITDA — Year-on-Year Growth

SANDUPHQ YoY (Mar 2024 vs Mar 2025) — revenue -12.5%, net profit -100.0%, expenses -6.7%. Explore SANDUPHQ true value to estimate fundamental worth using multiple valuation models.

Revenue Growth

-12.5%

Year-over-Year

Net Profit Growth

-100.0%

Year-over-Year

Expense Growth

-6.7%

Year-over-Year

Assets Growth

+7.7%

Year-over-Year

Equity Growth

+2.4%

Year-over-Year

Investing Cash Flow Growth

+100.0%

Year-over-Year

SANDUPHQ Income Statement — Revenue, EBITDA & Net Profit

Sandu Pharmaceuticals revenue ₹14 Cr, EBITDA ₹1 Cr, net profit ₹0 Cr, EPS ₹0.34 (2025). For live price, earnings ratios and company overview, see Sandu Pharmaceuticals screener.

Periods ₹ Crores

Particulars	Mar 2025	Sept 2024	Mar 2024	Jun 2024	Dec 2024	Sept 2023	Mar 2023	Jun 2023	Dec 2023	Sept 2022	Mar 2022	Jun 2022	Dec 2022	Sept 2021	Jun 2021
Revenue	14	18	16	17	18	17	15	18	18	17	12	16	17	18	17
Expenses	14	17	15	17	17	16	15	17	17	16	11	16	16	17	17
EBITDA	1	1	1	0	1	1	1	0	1	1	1	0	1	1	1
Operating Profit Margin %	3.00%	5.00%	4.00%	2.00%	5.00%	5.00%	3.00%	2.00%	3.00%	5.00%	5.00%	2.00%	5.00%	5.00%	4.00%
Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	0	1	1	0	1	1	0	0	0	1	0	0	1	1	1
Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Profit	0	1	1	0	1	1	0	0	0	1	0	0	1	0	0
Earnings Per Share (₹)	0.34	1.95	0.62	0.17	0.57	0.57	0.26	0.11	0.21	0.64	0.34	0.19	0.51	0.57	0.53

SANDUPHQ Balance Sheet — Assets, Liabilities & Shareholders' Equity

SANDUPHQ total assets ₹56 Cr, total equity ₹42 Cr, total liabilities ₹ Cr (2025).

Years Annual Data ₹ Crores

Particulars	2025	2024	2023
ASSETS
Total Assets	56	52	54
Current Assets	26	22	26
Fixed Assets	18	18	17
Capital Work in Progress	0	0	0
Investments	11	10	10
Other Assets	26	24	28
LIABILITIES
Total Liabilities
Current Liabilities	2	1	1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity	42	41	39
Share Capital	10	10	10
Reserves & Surplus	32	31	30

SANDUPHQ Cash Flow Statement — Operating, Investing & Financing

Sandu Pharmaceuticals operating cash flow ₹1 Cr, investing ₹0 Cr, financing ₹-1 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores

Particulars	March 2025	March 2024	March 2023
Operating Activities	1	1	0
Investing Activities	0	-1	1
Financing Activities	-1	-1	1
Net Cash Flow	0	-1	1